FibroGen, Inc. (NASDAQ:FGEN) Q1 2021 Earnings Conference Call May 10, 2021 5:00 PM ET Company Participants Michael Tung - Vice President of Corporate Strategy and Investor Relations Enrique Conterno - Chief Executive Officer Pat Cotroneo - Chief Financial Officer Mark Eisner - Chief Medical Officer Thane Wettig - Chief Commercial Officer Chris Chung - Senior Vice President, China Operations Conference Call Participants Annabel Samimy - Stifel Michael Yee - Jefferies Edwin Zhang - H.C. Wainwright Jason Gerbe ...

FibroGen, Inc. (NASDAQ:FGEN) Q4 2020 Earnings Conference Call March 1, 2021 5:00 PM ET Company Participants | --- | --- | |---------------------------------------------|-------| | | | | Michael Tung – Investor Relations Executive | | | Enrique Conterno – Chief Executive Officer | | | Mark Eisner – Chief Medical Officer | | | Pat Cotroneo – Chief Financial Officer | | | Conference Call Participants | | | Joel Beatty – Citi | | | Michael Yee – Jefferies | | | | | | Edwin Zhang – H.C. Wainwright | | | Geoffrey ...

FibroGen, Inc. Corporate Presentation November 2020 Forward-Looking Statements 2 This presentation contains "forward-looking" statements that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this presentation, including statements regarding our future financial condition, business strategy, and plans, and objectives of management for future operations, are forward looking statements. These forward-looking statements can generally be identifie ...

FibroGen, Inc. (NASDAQ:FGEN) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Michael Tung – Vice President-Corporate Strategy & Investor Relations Enrique Conterno - Chief Executive Officer Pat Cotroneo - Chief Financial Officer Thane Wettig - Chief Commercial Officer Peony Yu - Chief Medical Officer Chris Chung - Senior Vice President, China Operations Conference Call Participants Michael Yee – Jefferies Annabel Samimy - Stifel Geoffrey Porges - SVB Leerink Yaron Werber - ...

FibroGen, Inc. Corporate Presentation September 2020 Forward-Looking Statements 2 This presentation contains "forward-looking" statements that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this presentation, including statements regarding our future financial condition, business strategy, and plans, and objectives of management for future operations, are forward looking statements. These forward-looking statements can generally be identifi ...

FibroGen, Inc. (NASDAQ:FGEN) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Michael Tung – Vice President-Corporate Strategy and Investor Relations Enrique Conterno – Chief Executive Officer Pat Cotroneo – Chief Financial Officer Chris Chung – Senior Vice President-China Operations Thane Wettig – Chief Commercial Officer Peony Yu – Chief Medical Officer Conference Call Participants Geoffrey Porges – SVB Leerink Michael Yee – Jefferies Joel Beatty – Citi Jason Gerberry – Bank ...

FibroGen, Inc. (NASDAQ:FGEN) Q1 2020 Earnings Conference Call May 7, 2020 5:00 PM ET Corporate Participants Mike Tung - Investor Relations Enrique Conterno - Chief Executive Officer Peony Yu - Chief Medical Officer Chris Chung - Senior Vice President, China Operations Elias Kouchakji - Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance Pat Cotroneo - Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Geoffrey Porges - SVB Leerink Jason Gerberry - Bank of ...

FibroGen, Inc. (NASDAQ:FGEN) Q4 2019 Earnings Conference Call March 2, 2020 5:00 PM ET Company Participants Mike Tung - Investor Relations Enrique Conterno - Chief Executive Officer Peony Yu - Chief Medical Officer Chris Chung - Senior Vice President, China Operations Elias Kouchakji - Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance Pat Cotroneo - Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Geoffrey Porges - SVB Leerink Andy Hsieh - William Bla ...

FibroGen, Inc. Corporate Presentation January 2020 Forward-Looking Statements This presentation contains "forward-looking" statements that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this presentation, including statements regarding our future financial condition, business strategy, and plans, and objectives of management for future operations, are forward looking statements. These forward-looking statements can generally be identified b ...